Medicare Enrolled
Dr. David Perlmutter, M.D.
Ophthalmology · Albany, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perlmutter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perlmutter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perlmutter
Dr. David Perlmutter is an ophthalmology specialist in Albany, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Perlmutter performed 19,628 Medicare services across 5,598 unique beneficiaries.
Between the years covered by Open Payments, Dr. Perlmutter received a total of $34,661 from 46 pharmaceutical and/or device companies across 655 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perlmutter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 3% volume in NY
$34,661 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,628
Medicare services
Top 3% in NY for ophthalmology
5,598
Unique beneficiaries
$147
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,227 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
6,840 | $29 | $50 |
| Aflibercept eye injection (Eylea) | 2,432 | $693 | $1,470 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
2,081 | $30 | $88 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,390 | $90 | $269 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
863 | $86 | $204 |
| Ranibizumab-nuna biosimilar injection, 0.1 mg An injection of the biosimilar medication ranibizumab-nuna (Byooviz) at a dose of 0.1 mg. |
840 | $171 | $700 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
811 | $17 | $126 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
596 | $85 | $260 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
517 | $26 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
482 | $63 | $150 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
408 | $407 | $2,500 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
338 | $25 | $75 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
331 | $43 | $156 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
327 | $24 | $86 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
272 | $265 | $500 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
261 | $17 | $106 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
192 | $106 | $313 |
| Ranibizumab-eqrn injection, 0.1 mg An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose. |
145 | $214 | $700 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
80 | $91 | $289 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
61 | $11 | $103 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
52 | $101 | $215 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
51 | $248 | $649 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
48 | $615 | $1,500 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
38 | $562 | $2,900 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
36 | $1,728 | $3,778 |
| Cataract removal with artificial lens and drainage device insertion Surgical removal of the eye's natural lens followed by the insertion of an artificial lens and a drainage device into the front chamber of the eye. |
35 | $262 | $2,800 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
33 | $178 | $749 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
30 | $21 | $60 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
25 | $7 | $29 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $23 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
73.7% medium
24.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,661
Total received (2018-2024)
Avg $4,952/year across 7 years
Top 5% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
655
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19,410 (56.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,251 (44.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,196
2023
$4,108
2022
$4,609
2021
$6,989
2020
$8,549
2019
$2,278
2018
$2,932
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$1,636
Astellas Pharma US Inc
$1,044
Alcon Vision LLC
$445
ABBVIE INC.
$379
Bausch & Lomb Americas Inc.
$337
Ocular Therapeutix, Inc.
$222
Glaukos Corporation
$213
Genentech USA, Inc.
$176
Sight Sciences, Inc.
$142
Harrow Eye, LLC
$135
Tarsus Pharmaceuticals, Inc.
$100
Oyster Point Pharma, Inc.
$99
Apellis Pharmaceuticals, Inc.
$85
Sandoz Inc.
$79
Mallinckrodt Hospital Products Inc.
$67
Johnson & Johnson Surgical Vision, Inc.
$22
Rayner Intraocular Lenses Limited
$15
Top 3 companies account for 60.2% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$18,413
Alcon Vision LLC
$2,174
Glaukos Corporation
$1,620
Astellas Pharma US Inc
$1,361
Aerie Pharmaceuticals, Inc.
$1,238
ABBVIE INC.
$954
Johnson & Johnson Surgical Vision, Inc.
$947
Bausch & Lomb Americas Inc.
$658
Bausch & Lomb, a division of Bausch Health US, LLC
$645
Allergan Inc.
$595
Ocular Therapeutix, Inc.
$593
Genentech USA, Inc.
$590
Novartis Pharmaceuticals Corporation
$529
Sun Pharmaceutical Industries Inc.
$521
Sight Sciences, Inc.
$492
Alimera Sciences, Inc.
$378
Mallinckrodt Hospital Products Inc.
$360
Shire North American Group Inc
$328
Oyster Point Pharma, Inc.
$248
Alcon Laboratories Inc
$176
Horizon Therapeutics plc
$171
Kala Pharmaceuticals, Inc.
$164
Harrow Eye, LLC
$154
Dompe US, Inc.
$147
Spark Therapeutics, Inc.
$130
Allergan, Inc.
$106
Apellis Pharmaceuticals, Inc.
$104
Tarsus Pharmaceuticals, Inc.
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$94
Mallinckrodt LLC
$85
Sandoz Inc.
$79
Visioneering Technologies, Inc.
$65
Thea Pharma Inc.
$55
Omeros Corporation
$55
Mallinckrodt Enterprises LLC
$42
Coherus Biosciences Inc.
$41
Leadiant Biosciences, Inc.
$39
EyePoint Pharmaceuticals US, Inc.
$37
Rayner Intraocular Lenses Limited
$30
TissueTech, Inc.
$30
Biogen, Inc.
$28
Alexion Pharmaceuticals, Inc.
$21
ANI Pharmaceuticals, Inc.
$21
Beaver-Visitec International, Inc.
$17
TISSUETECH, INC.
$16
Eyevance Pharmaceuticals LLC
$14
Top 3 companies account for 64.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · BEOVU · BESIVANCE · BromSite (bromfenac ophthalmic solution) 0.075% · CATALYS Laser System · CEQUA · COMBIGAN · Centurion · Cequa · Cimerli · Clareon · Cystaran · DEXTENZA · DEXYCU · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Flarex · HYDRUS Microstent · IHEEZO · ILUVIEN · ILUX · INVELTYS · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · Iluvien · Izervay · LOTEMAX SM · LUMIGAN · LUXTURNA · Lucentis · Luxor · MIEBO · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · OZURDEX · Omidria · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · Prokera · RESTASIS · ReSTOR · ReSure Sealant · Rhopressa · Rocklatan · SUSVIMO · Simbrinza · Soliris · Syfovre · TECNIS Presbyopia-Correcting IOLs · TEPEZZA · TYRVAYA · TearCare SmartLid · Tecnis 1-piece IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · Tecnis Symfony IOL · Tecnis Toric 1-piece IOL · UPLIZNA · VABYSMO · VEVYE · VISUDYNE · VUITY · VYZULTA · Vabysmo · XDEMVY · XELPROS · XELPROS (latanoprost ophthalmic emulsion) 0.005% · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · XIPERE · enVista MX60 IOL · iDose · iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM · iStent inject Trabecular Micro-Bypass Stent System · iStent inject W · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for ophthalmology in NY.
Geographic Context
Ophthalmologists within 10 mi
88
Per 100K population
27.9
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Perlmutter is a mixed practice specialist, with above-average Medicare volume (top 3% in NY), with speaking/promotional industry engagement in the top 5% of NY peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Perlmutter experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Perlmutter performed 6,840 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perlmutter receive payments from pharmaceutical companies?
Yes. Dr. Perlmutter received a total of $34,661 from 46 companies across 655 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perlmutter's costs compare to other ophthalmologists in Albany?
Dr. Perlmutter's average Medicare payment per service is $147. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perlmutter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Albany
Browse ophthalmologists in Albany ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in NY
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in NY
Which NY ophthalmologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Alcon Vision LLC Payments to Doctors
See all physicians who received payments from Alcon Vision LLC.
By company
Glaukos Corporation Payments to Doctors
See all physicians who received payments from Glaukos Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology